COSCIENS Biopharma Inc T.CSCI

Alternate Symbol(s): CSCI

Healthcare Biotechnology

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.

TSX:CSCI - Post by User

COSCIENS Biopharma Inc

<< Previous

Bullboard Posts

Next >>

Post by archeo753on Nov 12, 2024 10:41am

82 Views

Post# 36308239

Market Cap

Market Cap today $16,931,821
$20.0 million in cash and cash equivalents at September 30, 2024

Looks like we are in for more pain during tax loss sell off. No new calalysts in near term. New CEO maybe sometime in January.

<< Previous

Bullboard Posts

Next >>

Nvidia reports record revenue in Q3